NMRA – neumora therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Neumora Therapeutics (NASDAQ:NMRA) was upgraded by analysts at Royal Bank Of Canada from a "sector perform" rating to an "outperform" rating.
Neumora Therapeutics (NASDAQ:NMRA) had its price target raised by analysts at Stifel Nicolaus from $2.00 to $3.00. They now have a "hold" rating on the stock.
Neumora Therapeutics GAAP EPS of -$0.35 misses by $0.02 [Seeking Alpha]
Neumora Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Update
Neumora Therapeutics to Participate in Upcoming Conferences in November
Form 8-K Neumora Therapeutics, For: Nov 17
Form 144 Neumora Therapeutics, Filed by: Aurora Daljit Singh
Form 10-Q Neumora Therapeutics, For: Sep 30
Form 8-K Neumora Therapeutics, For: Nov 06
Form 4 Neumora Therapeutics, For: Oct 27 Filed by: Burow Kristina
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.